Clinical trial
MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell…
NCT00427102 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Terminated
Key facts
| NCT number | NCT00427102 |
|---|---|
| Title | MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck |
| Official title | A Phase 1 Study of Oral MRX-1024 in Combination With Standard Fractionation Radiation Therapy and High-Dose Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck Following Surgical Resection |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Squamous Cell Carcinoma, Head and Neck Cancer, Resected Head and Neck Cancer, Mucositis |
| Intervention type | Drug, Procedure |
| Interventions | Oral MRX-1024, Standard Fractionation Radiation Therapy, High-Dose Cisplatin Chemotherapy |
| Start date | Jan 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jan 26, 2007 |
| Last update posted | Nov 14, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: